UKBizDB.co.uk

ENHANC3D GENOMICS LTD

PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)

This company is commonly known as Enhanc3d Genomics Ltd. The company was founded 5 years ago and was given the registration number 12423696. The firm's registered office is in CAMBRIDGE. You can find them at Babraham Institute Building 570, Babraham Research Campus, Cambridge, . This company's SIC code is 72110 - Research and experimental development on biotechnology.

Company Information

Name:ENHANC3D GENOMICS LTD
Company Number:12423696
Company Type:PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
Status:Active
Incorporation Date:24 January 2020
End of financial year:31 December 2022
Jurisdiction:England - Wales
Industry Codes:
  • 72110 - Research and experimental development on biotechnology

Office Address & Contact

Registered Address:Babraham Institute Building 570, Babraham Research Campus, Cambridge, United Kingdom, CB22 3AT
Country Origin:UNITED KINGDOM
Telephone:Unreported
Email Address:Unreported
Website:Unreported
Social:Unreported

Company Officers

Personal InformationRoleAppointedStatus
Suite 1, The Jeffreys Building,, St John's Innovation Park, Cowley Road, Cambridge, United Kingdom, CB4 0DS

Secretary28 May 2021Active
30, Uilstraat 30, Hasselt, Belgium, B-3500

Director30 March 2021Active
Suite 1, The Jeffreys Building,, St John's Innovation Park, Cowley Road, Cambridge, United Kingdom, CB4 0DS

Director14 October 2022Active
Suite 1, The Jeffreys Building,, St John's Innovation Park, Cowley Road, Cambridge, United Kingdom, CB4 0DS

Director25 August 2022Active
3, Pancras Square, London, England, N1C 4AG

Corporate Director25 August 2022Active
Babraham Institute, Building 570, Babraham Research Campus, Cambridge, United Kingdom, CB22 3AT

Director04 January 2021Active
Babraham Institute, Building 570, Babraham Research Campus, Cambridge, United Kingdom, CB22 3AT

Director24 January 2020Active
Suite 1, The Jeffreys Building,, St John's Innovation Park, Cowley Road, Cambridge, United Kingdom, CB4 0DS

Director05 August 2020Active
Milner Therapeutics Institute, Puddicombe Way, Cambridge, England, CB2 0AW

Director30 March 2021Active
Bgf Investments Lp 13-15, York Buildings, London, England, WC2N 6JU

Director25 August 2022Active
Babraham Institute, Building 570, Babraham Research Campus, Cambridge, United Kingdom, CB22 3AT

Director24 January 2020Active
Babraham Institute, Building 570, Babraham Research Campus, Cambridge, United Kingdom, CB22 3AT

Director24 January 2020Active

People with Significant Control

Bioqube Factory Fund I Commv
Notified on:30 March 2021
Status:Active
Country of residence:Belgium
Address:13, Barricadenplein, Brussels, Belgium, B-1000
Nature of control:
  • Ownership of shares 25 to 50 percent
Prof Peter John Fraser
Notified on:08 December 2020
Status:Active
Date of birth:May 1956
Nationality:American
Country of residence:United Kingdom
Address:Babraham Institute, Building 570, Cambridge, United Kingdom, CB22 3AT
Nature of control:
  • Ownership of shares 25 to 50 percent
  • Voting rights 25 to 50 percent
Dr Mikhail Spivakov
Notified on:24 January 2020
Status:Active
Date of birth:April 1980
Nationality:British
Country of residence:United Kingdom
Address:Babraham Institute, Building 570, Cambridge, United Kingdom, CB22 3AT
Nature of control:
  • Ownership of shares 25 to 50 percent
  • Voting rights 25 to 50 percent
  • Right to appoint and remove directors
Dr Stefan Walter Schoenfelder
Notified on:24 January 2020
Status:Active
Date of birth:July 1973
Nationality:German
Country of residence:United Kingdom
Address:Babraham Institute, Building 570, Cambridge, United Kingdom, CB22 3AT
Nature of control:
  • Ownership of shares 25 to 50 percent
  • Voting rights 25 to 50 percent
  • Right to appoint and remove directors
Prof Peter John Fraser
Notified on:24 January 2020
Status:Active
Date of birth:May 1956
Nationality:American
Country of residence:United Kingdom
Address:Babraham Institute, Building 570, Cambridge, United Kingdom, CB22 3AT
Nature of control:
  • Ownership of shares 25 to 50 percent
  • Voting rights 25 to 50 percent
  • Right to appoint and remove directors

Account Documents

Accounts

  • Last accounts submitted for period 31 March 2023 (2 years ago)
  • Accounts type was MICRO
  • Next accounts dated 31 March 2024
  • Due by 31 December 2024 (10 months remaining)

Confirmation Statement

  • Last submitted on 14 October 2023 (2 years ago)
  • Next confirmation dated 14 October 2024
  • Due by 28 October 2024 (12 months remaining)

Table of Contents

Nearby Companies

Same Postcode

Copyright © 2025. All rights reserved.